The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss
Conditions
- Myeloma
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Smouldering Myeloma
Interventions
- OTHER: Diffusion Weighted Magnetic Resonance Imaging (DWMRI)
- OTHER: DXA scan
- OTHER: Bloods and urine
Sponsor
Oxford University Hospitals NHS Trust
Collaborators